# Neoadjuvant Tamoxifen in Locally Advanced Breast Cancer in a Low/Middle Income Country

> **NCT02806544** · PHASE2 · COMPLETED · sponsor: **Vanderbilt University** · enrollment: 35 (actual)

## Conditions studied

- Breast Cancer
- Breast Neoplasms

## Interventions

- **DRUG:** Tamoxifen

## Key facts

- **NCT ID:** NCT02806544
- **Lead sponsor:** Vanderbilt University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01
- **Primary completion:** 2014-09
- **Final completion:** 2014-09
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2017-01-30

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02806544

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02806544, "Neoadjuvant Tamoxifen in Locally Advanced Breast Cancer in a Low/Middle Income Country". Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/clinical/NCT02806544. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*